Issues in the manufacture and transplantation of genetically modified hematopoietic stem cells.

Abstract:

:The advent of safe and practical means to correct, enhance or protect blood cells at the genetic level offers tantalizing therapeutic perspectives. At present, gene delivery using a replication-defective retrovirus is the most efficient method to stably transduce hematopoietic cells. The successful adaptation of retroviral infection to hematopoietic stem cells requires optimized transduction conditions that maximize gene transfer while preserving the cells' potential for engraftment and longterm hematopoiesis. The successful establishment of effective transduction protocols hinges on retrovirus biology as well as stem cell and transplantation biology. Interestingly, the genetic approach could permit novel strategies to promote host repopulation by transplanted stem cells. However, regulated and predictable expression of any transgene integrated at random chromosomal locations cannot be taken for granted. Investigation of the control of transgene expression and prevention of vector silencing will become increasingly important.

journal_name

Curr Opin Hematol

authors

Sadelain M,Frassoni F,Rivière I

doi

10.1097/00062752-200011000-00008

keywords:

subject

Has Abstract

pub_date

2000-11-01 00:00:00

pages

364-77

issue

6

eissn

1065-6251

issn

1531-7048

journal_volume

7

pub_type

杂志文章,评审
  • Advances in the immunotherapy of hematologic malignancies: cellular and humoral approaches.

    abstract::Therapy with unconjugated monoclonal antibodies (mAbs) and radiolabeled mAbs has shown activity in patients with B-cell non-Hodgkin's lymphoma and leukemia. Drug-conjugated mAbs are active in relapsed leukemia. Using these new agents with and after chemotherapy induces a high rate of remission, but this needs to be co...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199907000-00005

    authors: Maloney DG

    更新日期:1999-07-01 00:00:00

  • Update on thrombopoietin in preclinical and clinical trials.

    abstract::Thrombopoietin, also termed the c-Mpl ligand, is a lineage-dominant hematopoietic factor that primarily regulates megakaryopoiesis and thrombopoiesis. Treatment of normal animals with recombinant human megakaryocyte growth and development factor, a truncated molecule of the c-Mpl ligand, which is modified with polyeth...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199805000-00009

    authors: Miyazaki H

    更新日期:1998-05-01 00:00:00

  • Polycythemia vera and other primary polycythemias.

    abstract:PURPOSE OF REVIEW:Diagnosis and therapy of polycythemia vera are controversial since the molecular basis of polycythemia vera remains unknown. Distinguishing between polycythemia vera and other polycythemic disorders can be very challenging. The purpose of this review is to discuss the recent progress in this area and ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000154029.05396.d2

    authors: Prchal JT

    更新日期:2005-03-01 00:00:00

  • Antimicrobial peptides of leukocytes.

    abstract::Leukocytes use an array of antimicrobial peptides and proteins to help them destroy invading microorganisms. These endogenous antibiotic molecules are remarkable for their structural variety, rapid evolutionary divergence, intraspecies variation, and complex yet subtle interactions with their targets. This arsenal has...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704010-00009

    authors: Ganz T,Lehrer RI

    更新日期:1997-01-01 00:00:00

  • New insights into functions of erythroid proteins in nonerythroid cells.

    abstract::This article presents new insights into potential roles that three erythrocyte cytoskeletal proteins, protein 4.1, ankyrin, and spectrin, may play in nonerythroid nucleated cells. Each of these proteins is encoded by several closely related genes characterized by complex alternative splicing of their pre-mRNA, thus re...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200003000-00009

    authors: Gascard P,Mohandas N

    更新日期:2000-03-01 00:00:00

  • Optimal dosing and triggers for prophylactic use of platelet transfusions.

    abstract::Despite the reliance on platelet transfusion support in patients receiving myeloablative therapy, controversies surround platelet transfusion practices. These include the appropriate platelet dose and the threshold at which prophylactic platelet transfusions will be most effective. These issues bear directly on patien...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199911000-00015

    authors: Rinder HM,Arbini AA,Snyder EL

    更新日期:1999-11-01 00:00:00

  • The modern landscape of transfusion-related iatrogenic Creutzfeldt-Jakob disease and blood screening tests.

    abstract::The idea that blood in naturally occurring transmissible spongiform encephalopathies is not infectious has imploded in the face of recent transmissions from the blood of naturally occurring scrapie in sheep and of variant Creutzfeldt-Jakob disease in humans. Although donor exclusion criteria ensure that the number of ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000143393.49202.f0

    authors: Brown P,Cervenakova L

    更新日期:2004-09-01 00:00:00

  • The metabolism of lymphomas.

    abstract:PURPOSE OF REVIEW:Cellular to animal to human studies are shedding light on metabolic pathways that contribute to sustaining lymphomagenesis. Old players with new metabolic tricks and new metabolic players come into the scene. The purpose of this review is to discuss the recent advances made in the field of lymphoma me...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3283623d16

    authors: Calvo-Vidal MN,Cerchietti L

    更新日期:2013-07-01 00:00:00

  • Activated T cells armed with bispecific antibodies kill tumor targets.

    abstract:PURPOSE OF REVIEW:Adoptive T-cell therapy has become one of the most exciting fields of cancer therapy in the past few years. In this article, we describe a method which combines adoptive T-cell therapy with antibody therapy by arming T cells from cord blood, normal patients, and cancer patients with bispecific antibod...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000176

    authors: Bhutani D,Lum LG

    更新日期:2015-11-01 00:00:00

  • Endothelial cell biology of Endoglin in hereditary hemorrhagic telangiectasia.

    abstract:PURPOSE OF REVIEW:Mutations in the Endoglin (Eng) gene, an auxiliary receptor in the transforming growth factor beta (TGFβ)-superfamily signaling pathway, are responsible for the human vascular disorder hereditary hemorrhagic telangiectasia (HHT) type 1, characterized in part by blood vessel enlargement. A growing body...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000419

    authors: Sugden WW,Siekmann AF

    更新日期:2018-05-01 00:00:00

  • Monitoring minimal residual disease in patients with chronic myeloid leukemia after treatment with tyrosine kinase inhibitors.

    abstract:PURPOSE OF THE REVIEW:Monitoring for residual leukemic burden is an integral part of ongoing evaluation in chronic myeloid leukemia. With high rates of complete cytogenetic response induced by imatinib and other tyrosine kinase inhibitors, exploring refinements in current methods of minimal residual disease monitoring ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e3282f42898

    authors: Sahay T,Schiffer CA

    更新日期:2008-03-01 00:00:00

  • Novel strategies for steroid-refractory acute graft-versus-host disease.

    abstract:PURPOSE OF REVIEW:Graft-versus-host disease is one of the commonest complications of allogeneic bone marrow or peripheral blood stem cell transplantation. This review will cover advances in the pathophysiology of graft-versus-host disease and new agents under investigation for the treatment of this disorder. Patients d...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/01.moh.0000148763.12733.bb

    authors: Bolaños-Meade J,Vogelsang GB

    更新日期:2005-01-01 00:00:00

  • The use of granulocyte colony-stimulating factor for treatment of autoimmune neutropenia.

    abstract::The advent of better diagnostic tools, molecular techniques, and cytokine therapies have come together at the end of the 20th century to provide an improved outlook for patients with autoimmune neutropenia. Severe chronic neutropenia is no longer idiopathic in most cases, and growth factor therapy can be safely offere...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200105000-00007

    authors: Smith MA,Smith JG

    更新日期:2001-05-01 00:00:00

  • The role of PI3K/protein kinase B (PKB/c-akt) in migration and homing of hematopoietic stem and progenitor cells.

    abstract:PURPOSE OF REVIEW:Hematopoietic stem cell (HSC) transplantation is the most powerful treatment modality for a variety of hematological disorders. Successful hematopoietic recovery after transplantation depends on optimal homing of HSCs to the bone marrow and subsequent lodging in the HSC niche. The molecular mechanisms...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32834760e5

    authors: Buitenhuis M

    更新日期:2011-07-01 00:00:00

  • Leukocyte interaction with protein cascades in blood coagulation.

    abstract::Coagulation preserves the homeostasis of internal body fluids against life-threatening blood losses. Although generally viewed as a regulated enzymatic cascade, this mechanism depends on the participation of vascular cells. Leukocytes, in particular, have evolved a formidable machinery to initiate and amplify blood cl...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199502010-00006

    authors: Altieri DC

    更新日期:1995-01-01 00:00:00

  • Platelet transfusion support for patients with cancer and hematologic malignancies.

    abstract::Advances in platelet transfusion have contributed to improved outcomes in the treatment of patients with cancer and leukemia. However, the optimal strategies to avoid some of the side effects that could result from platelet transfusions remain under investigation. These side effects include the development of refracto...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199603050-00003

    authors: Sarkodee-Adoo C,Schiffer CA

    更新日期:1996-09-01 00:00:00

  • Clinical relevance of microparticles from platelets and megakaryocytes.

    abstract:PURPOSE OF REVIEW:Platelet microparticles were identified more than 40 years ago and are the most abundant circulating microparticle subtype. Yet fundamental questions about their formation and role in human disease are just beginning to be understood at the cellular and molecular level. This review will address mechan...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32833e77ee

    authors: Italiano JE Jr,Mairuhu AT,Flaumenhaft R

    更新日期:2010-11-01 00:00:00

  • The platelet release reaction: just when you thought platelet secretion was simple.

    abstract:PURPOSE OF REVIEW:In response to agonists produced at vascular lesions, platelets release a host of components from their three granules: dense core, alpha, and lysosome. This releasate activates other platelets, promotes wound repair, and initiates inflammatory responses. Although widely accepted, the specific mechani...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328309ec74

    authors: Ren Q,Ye S,Whiteheart SW

    更新日期:2008-09-01 00:00:00

  • Safety of long-term administration of granulocyte colony-stimulating factor for severe chronic neutropenia.

    abstract::When a new product with huge clinical potential explodes on the scene, the hope is that the benefits far outweigh the risks in long-term administration. After 10 years of clinical use, granulocyte colony-stimulating factor (G-CSF) has lived up to that promise so far. In the context of severe chronic neutropenia, more ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704030-00011

    authors: Freedman MH

    更新日期:1997-05-01 00:00:00

  • Stem cell transplantation for primary immune deficiency.

    abstract:PURPOSE OF REVIEW:In this article, we summarize the recent advances in treating primary immune deficiency (PID) disorders by stem cell transplantation (SCT); we have focused on articles published in the past 2 years since the last major review of SCT for PID. RECENT FINDINGS:Analyses of the outcomes of SCT for PID by ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e328365a13b

    authors: Worth AJ,Booth C,Veys P

    更新日期:2013-11-01 00:00:00

  • Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia.

    abstract:PURPOSE OF REVIEW:To review the data on angiogenesis related to exosomes secreted by tumor cells in hematologic neoplasia and to elucidate the role of exosomes and exosomal miRNA in the bone marrow microenvironment, especially under hypoxic conditions. RECENT FINDINGS:Cross-talk between bone marrow tumor cells and sur...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000235

    authors: Ohyashiki JH,Umezu T,Ohyashiki K

    更新日期:2016-05-01 00:00:00

  • The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease.

    abstract::Platelet aggregation, a process mediated by GP IIb-IIIa, is responsible for the occlusive events in thrombosis: indeed, GP IIb-IIIa antagonists are effective in blocking arterial thrombosis. Recent studies have suggested that activated platelets and platelet thrombi can contribute significantly to the initiation and p...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200309000-00006

    authors: Prasad KS,Andre P,Yan Y,Phillips DR

    更新日期:2003-09-01 00:00:00

  • Purging marrow or peripheral blood stem cells for autografting.

    abstract::Myeloablative therapy followed by autologous bone marrow or peripheral blood stem cell rescue is an alternative therapeutic option for patients who are not candidates for allogeneic transplantation due to the lack of an appropriate HLA-matched donor or to advanced age. It allows therapy to be administered that is of c...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199704060-00011

    authors: Hammert LC,Ball ED

    更新日期:1997-11-01 00:00:00

  • Molecular insights into early hematopoiesis.

    abstract::During embryogenesis, a pool of pluripotential, self-renewing hematopoietic stem cells is specified from undifferentiated ventral mesoderm. These cells proliferate and differentiate to yield all the peripheral blood lineages. Although the mechanisms involved in the commitment and differentiation of multipotential prog...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-199803000-00012

    authors: Mead PE,Zon LI

    更新日期:1998-03-01 00:00:00

  • The clinical consequences of neutrophil priming.

    abstract:PURPOSE OF REVIEW:Neutrophils priming has been long studied in vitro. Recent studies describe it in vivo. In pathophysiological conditions, complex, heterogeneous characteristics of priming are described in the last few years. RECENT FINDINGS:Priming can occur systemically when insults such as sepsis or trauma result ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000471

    authors: Vogt KL,Summers C,Condliffe AM

    更新日期:2019-01-01 00:00:00

  • Recent advances in multiple myeloma.

    abstract::Multiple myeloma is the second most common hematologic malignancy, with approximately 15,000 new cases each year in the United States. Our understanding of the pathophysiology underlying myeloma continues to expand, but the cause of this plasma cell dyscrasia remains unclear. Though controversy remains regarding a pos...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/00062752-200007000-00007

    authors: Sjak-Shie NN,Vescio RA,Berenson JR

    更新日期:2000-07-01 00:00:00

  • Seasonal blood shortages can be eliminated.

    abstract:PURPOSE OF REVIEW:This review is designed to help readers understand seasonal blood shortages and provide solutions through the use of technology that can increase the number of red blood cell units collected and the use of recruitment and marketing initiatives that appeal to the increasingly diverse donor base. RECEN...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/01.moh.0000180436.98990.ce

    authors: Gilcher RO,McCombs S

    更新日期:2005-11-01 00:00:00

  • Stem cell regulatory niches and their role in normal and malignant hematopoiesis.

    abstract:PURPOSE OF REVIEW:In the postnatal life, hematopoietic stem cell (HSC) niches are specialized microenvironments in the bone marrow that are essential for the maintenance and function of HSCs. The purpose of this review is to discuss the concept of HSC niche in light of recent studies that broaden its complexity and bet...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0b013e32833a25d8

    authors: Carlesso N,Cardoso AA

    更新日期:2010-07-01 00:00:00

  • Regulation of the hematopoietic stem cell lifecycle by the endothelial niche.

    abstract:PURPOSE OF REVIEW:Hematopoietic stem cells (HSCs) predominantly reside either in direct contact or in close proximity to the vascular endothelium throughout their lifespan. From the moment of HSC embryonic specification from hemogenic endothelium, endothelial cells (ECs) act as a critical cellular-hub that regulates a ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章,评审

    doi:10.1097/MOH.0000000000000350

    authors: Ramalingam P,Poulos MG,Butler JM

    更新日期:2017-07-01 00:00:00

  • Transfusion triggers for blood components.

    abstract::Whereas there are general guidelines for acceptable transfusion therapy, optimal transfusion therapy has not been determined for most clinical settings. Recent research has focused on controlled studies of red cell transfusion in specific clinical settings. Better determinations of oxygen delivery and consumption are ...

    journal_title:Current opinion in hematology

    pub_type: 杂志文章

    doi:10.1097/00062752-200111000-00012

    authors: Clark P,Mintz PD

    更新日期:2001-11-01 00:00:00